Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
International Journal of Computer Assisted Radiology and Surgery
|
November 15, 2017
Real-time wireless tumor tracking during breast conserving surgery
Natasja Janssen, Roeland Eppenga, Marie-Jeanne Vrancken Peeters, et al.
Nature Clinical Practice. Oncology
|
October 5, 2006
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
Jan Bogaerts, Fatima Cardoso, Marc Buyse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase
Emiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial
Sophie C J Bosma, Femke Leij, Sandra Vreeswijk, et al.
Journal of the National Cancer Institute
|
September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse, Sherene Loi, Laura van't Veer, et al.
Communications Biology
|
July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial
Laurent Jacob, Anke Witteveen, Inès Beumer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2026
Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial
Christine Desmedt, Ha-Linh Nguyen, François Richard, et al.
Genes
|
May 19, 2018
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study
Julia E C van Steenhoven, Anne Kuijer, Paul J van Diest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial
Suzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
The New England Journal of Medicine
|
August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
International Journal of Computer Assisted Radiology and Surgery
|
November 15, 2017
Real-time wireless tumor tracking during breast conserving surgery
Natasja Janssen, Roeland Eppenga, Marie-Jeanne Vrancken Peeters, et al.
Nature Clinical Practice. Oncology
|
October 5, 2006
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
Jan Bogaerts, Fatima Cardoso, Marc Buyse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2011
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase
Emiel Rutgers, Martine J Piccart-Gebhart, Jan Bogaerts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 29, 2020
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial
Sophie C J Bosma, Femke Leij, Sandra Vreeswijk, et al.
Journal of the National Cancer Institute
|
September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse, Sherene Loi, Laura van't Veer, et al.
Communications Biology
|
July 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial
Laurent Jacob, Anke Witteveen, Inès Beumer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 17, 2026
Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial
Christine Desmedt, Ha-Linh Nguyen, François Richard, et al.
Genes
|
May 19, 2018
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study
Julia E C van Steenhoven, Anne Kuijer, Paul J van Diest, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2020
Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial
Suzette Delaloge, Martine Piccart, Emiel Rutgers, et al.
The New England Journal of Medicine
|
August 25, 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, et al.
Page
of 4